Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas

NCT00948688 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Funding was withdrawn after only 10 participants were enrolled

Conditions

Pancreatic Cancer
Adenocarcinoma of the Pancreas

Interventions

RADIATION: Radiation therapy
DRUG: 5-FU
DRUG: Vorinostat

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]
[object Object]